Healthcare experiences of autistic transgender adults
Part of Mental health clinical trials.
This study explores the healthcare experiences of autistic transgender and gender diverse (TGD) adults who have used or tried to use NHS gender identity clinics in the UK. Participation involves completing a demographic questionnaire and sharing your experiences.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a formal diagnosis of autism (you will be asked about this, but no proof needed).
- You must identify as transgender, nonbinary, or another gender diverse identity.
- You must have accessed, previously accessed, or tried to access NHS gender identity clinics in the UK.
- You must be able to communicate in English (verbally or in writing).
- You must be able to provide your informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to improve healthcare for gender-diverse young adults (ages 18-29) and their caregivers. It involves a program to support transgender and nonbinary health and will take place online.
This study looks at how people with autism (and some without autism) react during a routine blood test. Researchers will watch and measure behavior and body responses to better understand distress and comfort during needle procedures.
This observational study looks at different groups of people with autism spectrum disorder (ASD) using existing medical records and caregiver reports. It may help researchers better understand what different autistic subgroups need, without giving an experimental treatment.
This study is testing a new questionnaire designed to measure how much people with autism 'camouflage' or hide their autistic traits. It aims to better understand this behavior in teens and young adults.
This study looks back at the medical records of transgender young people who began gender-affirming care at Strasbourg University Hospital before age 18. It helps doctors understand their experiences and improve future care.
This study looks at starting gender-affirming hormone therapy (GAHT) for transgender people who have never had these treatments before. It may help you learn whether this approach is safe and effective for your goals as you begin care.
Hear when a new Autism Spectrum Disorder (ASD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.